Hemcheck takes next step through the transaction with Bio Vitos
September 7, 2023 8:42 pmOn August 28, Hemcheck was conditionally approved for continued listing on Nasdaq. After that, a lot of work has been done to implement all the…
On August 28, Hemcheck was conditionally approved for continued listing on Nasdaq. After that, a lot of work has been done to implement all the…
Hemcheck has been approved for continued listing by Nasdaq, subject to the transaction with Bio Vitos being completed and other customary conditions such as updating…
Hemcheck has received a first smaller order from Astemed, which is the company’s distributor in the United Arab Emirates. The order concerns instruments and v-Test…
Hemcheck Sweden AB has received a new follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests…
Hemcheck has received a first small order from the university hospital Charité in Berlin. Charité is one of the largest university hospitals in Europe with…
Hemcheck and Biovitos have signed an additional agreement which enables Hemcheck to send out a calling to the extra general shareholders meeting that will decide…
Hemcheck has received a first follow-up order from its Finnish distributor, Vingmed, which is also Hemcheck’s distributor in Sweden and Norway. The order concerns s-Test…
Hemcheck has received another follow-up order from its UK distributor, CLS. The order concerns instruments for diagnostic use and bgs-Test and is of lower economic…
Hemcheck Sweden AB has received a follow-up order from AREVA in the US. The order is a follow-up order after a first successful evaluation phase…
As previously communicated, if the conditional deal with Bio Vitos Medical Limited is approved, Hemcheck acquires IP rights regarding the use of iron succinate for…